GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

But oncology medicines form a small share of GSK's overall business, responsible for less than 5 per cent - $373million - of its $8billion revenues in the third quarter. During the period ...

And he should know – he was responsible for making GSK's Facebook page one of the ... "The way that we do business is just as important as what we achieve", adds Quayle. "You cannot be a company ...

GSK will also be responsible for success-based milestone payments as well as tiered royalties for IDRX-42 owed to Merck KGaA, Darmstadt, Germany. This transaction is subject to customary ...

GSK will also be responsible for success-based milestone payments as well as tiered royalties for IDRX-42 owed to German drug maker Merck KGaA (MKGAY.PK). GIST usually occurs in the GI tract ...